Susan D. Bromley,Francesco Parlati,Matthew I. Gross,Keith Orford
申请号：
US16492200
公开号：
US20200038398A1
申请日:
2018.03.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and a second anticancer agent such as osimertinib, pazopanib, navitoclax, palbociclib, or olaparib. The invention further relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and conventional radiotherapy or stereotactic body radiotherapy.
